Immunology

COVID-19 not characterised by a cytokine storm

Inflammatory proteins known as cytokines play a crucial role in the immune response. If this response is too strong – a phenomenon known as “cytokine storm” – it can cause harm to the patient.

One-to-one: COVID response controvery

We hear from Professor Sunetra Gupta – the theoretical epidemiologist who believes in herd immunity and doesn’t believe in the lockdown.

"Three times risk for frontline healthcare workers"

Frontline healthcare workers with adequate personal protective equipment (PPE) have a three-fold increased risk of a positive SARS-CoV-2 test, compared with the public.

Screening to improve mAb-based drugs

By screening potential monoclonal antibody (mAb)-based drugs solely on a measure of their colloidal stability, scientists may be able to weed out mAbs that do not respond efficiently in solution early in the drug discovery process, according to a new study.

Immune responses to COVID-19

Most newly discharged patients who recently recovered from COVID-19 produce virus-specific antibodies and T cells, suggests a new study.

June: Science news in numbers

A breakdown of science news this month, in numbers.

War on cancer: to screen or not to screen?

Steve Clarke on the history of screening tests and programme criteria, as applied to cancer screening, notably colorectal cancer.

In search of a vaccine

We look at the frontline of vaccine development and how and when immunity to COVID-19 may be a possibility.

"Childhood vaccines enhance cancer treatment"

Scientists claim new research shows that pre-immunisation, acquired through common childhood vaccines, can be used to enhance therapeutic cancer treatment.

January news in numbers

A breakdown of science news this month, in numbers.

Top